Vantage Health Forms Strategic Partnership with Theranostics Laboratory
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Vantage Health Inc., (OTCQB:VNTH) (“Vantage Health”) or (the “Company”) today announced that it has entered into a strategic partnership with Theranostics Laboratory, a translational research company, with offices in the USA and New Zealand. Theranostics laboratory was founded at the Cleveland Clinic in 2010 and works on subcontracted research, in collaboration with the Auckland Bioengineering Institute (ABI), in New Zealand, and with NASA (via NASA Grant NCC 9-58).
The Auckland Bioengineering Institute is recognised as a world-leader in the field of personalised modelling and is part of the international Virtual Physiologic Human (VPH) project (http://physiomeproject.org/). The Institute has successfully commercialised numerous mHealth technologies, including wireless telemetry systems, wearable sensors and a needle-free injectable system into the US market.
The partnership between the Theranostics laboratory and the Auckland Bioengineering Institute (ABI) is a strategic alliance for Vantage Health Inc, through which the lab will act as principal investigators for Vantage in the areas of mobile strep detection, mobile virus detection and other related areas including breath sample conditioning methodologies. The partnership gives Vantage Health access to world-class expertise and skill in the field of personalized modelling. It also provides the company with cost-efficiencies working across multiple time zones, as well as insight into the Australasian MedTech market.
About Vantage Health Inc.
Vantage Health Inc. – a mobile health technology company – is developing personalized and point-of-care screening using Apps based upon chemical sensing residing within a Bluetooth device that works with any smartphone. With its foundations in advanced nanotechnology, the company’s first product, the Vantage Health Sensor, which is in development, is the convergence of nano-electronics, bio-informatics, and wireless technology to create the next generation mobile health application. The first mobile App is expected to be for lung cancer screening with additional mobile healthcare Apps in the planning stages. The company has offices in Redwood City, CA and New York. For more information, please visithttp://www.vantagehealthinc.com
